Amano, S. | bioRxiv Science

bioRxiv2026

Dual-color fluorescent reporters resolve Alu and LINE-1 retrotransposition in single cells

LINE-1 (L1) is transcribed by RNA polymerase (Pol) II, whereas the non-coding Short INterspersed Element (SINE) Alu is transcribed by Pol III and exploits L1 ORF2p for mobilization. Conventional L1 retrotransposition reporters rely on spliceosome-dependent introns and cannot directly monitor Alu retrotransposition. Here, we developed EGFPTet, a fluorescent SINE reporter in which EGFP is interrupted by a Tetrahymena thermophila group I self-splicing intron. EGFPTet enabled flow cytometry, fluorescence microscopy, cell sorting, and time-course analysis of Alu mobilization without colony formation. Reporter activation required ORF2p reverse transcriptase activity, and recovered Alu-EGFPTet insertions displayed retrotransposition hallmarks. EGFPTet quantified Alu retrotransposition across cell lines and host-factor perturbations and was repurposed to detect mobilization of the phylogenetically distinct mouse B2 SINE. Defined amino acid substitutions generated an mTurquoise2 derivative without redesigning the self-splicing junctions, allowing dual-color analysis of Alu trans-mobilization and L1 cis retrotransposition in individual cells. In this assay, wild-type L1 supported a higher Alu retrotransposition frequency than the ORF1p-mutant L1. Despite their shared dependence on ORF2p, Alu co-expression did not significantly reduce L1 retrotransposition, and Alu/L1 dual-positive counts exceeded independence-based expectations, indicating preferential co-occurrence of the two reporter signals. EGFPTet provides a fluorescent platform for investigating the shared and distinct cellular conditions that support SINE and L1 mobilization.

molecular biology↗

bioRxiv2023

KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster

Arboleda-Tham Syndrome (ARTHS) is a rare genetic disorder caused by heterozygous, de novo truncating mutations in Lysine(K) acetyltransferase 6A (KAT6A). ARTHS is clinically heterogeneous and characterized by several common features including intellectual disability, developmental and speech delay, hypotonia and affects multiple organ systems. KAT6A is highly expressed in early development and plays a key role in cell-type specific differentiation. KAT6A is the enzymatic core of a histone-acetylation protein complex, however the direct histone targets and gene regulatory effects remain unknown. In this study, we use ARTHS patient (n=8) and control (n=14) dermal fibroblasts and perform comprehensive profiling of the epigenome and transcriptome caused by KAT6A mutations. We identified differential chromatin accessibility within the promoter or gene body of 23%(14/60) of genes that were differentially expressed between ARTHS and controls. Within fibroblasts, we show a distinct set of genes from the posterior HOXC gene cluster (HOXC10, HOXC11, HOXC-AS3, HOXC-AS2, HOTAIR) that are overexpressed in ARTHS and are transcription factors critical for early development body segment patterning. The genomic loci harboring HOXC genes are epigenetically regulated with increased chromatin accessibility, high levels of H3K23ac, and increased gene-body DNA methylation compared to controls, all of which are consistent with transcriptomic overexpression. Finally, we used unbiased proteomic mass spectrometry and identified two new histone post-translational modifications (PTMs) that are disrupted in ARTHS: H2A and H3K56 acetylation. Our multi-omics assays have identified novel histone and gene regulatory roles of KAT6A in a large group of ARTHS patients harboring diverse pathogenic mutations. This work provides insight into the role of KAT6A on the epigenomic regulation in somatic cell types.

genomics↗